Ancrod Stroke Study

Completed

Phase 3 Results

Summary of Purpose

To study the safety and efficacy of ancrod in patients with acute ischemic stroke administered within 6 hours of stroke onset.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 October 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Double-blind, randomized, placebo-controlled trial involving 132 patients at 18 U.S. and German centers.

Contacts

Not available